571 related articles for article (PubMed ID: 9108587)
1. Epidemiologic analysis of breast and gynecologic cancers.
Hulka BS
Prog Clin Biol Res; 1997; 396():17-29. PubMed ID: 9108587
[TBL] [Abstract][Full Text] [Related]
2. The prevention of breast cancer through reduced ovarian steroid exposure.
Spicer DV; Pike MC
Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
4. Researchers can now investigate long-term effects of OCs on cancer.
Rubin GL; Peterson HB
Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
[TBL] [Abstract][Full Text] [Related]
5. Neoplastic effects of oral contraceptives.
Grimes DA
Int J Fertil; 1991; 36 Suppl 1():19-24. PubMed ID: 1678377
[TBL] [Abstract][Full Text] [Related]
6. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
7. Links between hormone replacement therapy and neoplasia.
Hulka BS
Fertil Steril; 1994 Dec; 62(6 Suppl 2):168S-175S. PubMed ID: 7958013
[TBL] [Abstract][Full Text] [Related]
8. [Oral contraception and its beneficial gynecological effects].
Belaisch J; Hommais-loufrani B
Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
10. Does HRT modify risk of gynecological cancers?
Schneider HP; Birkhauser M
Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():40-53. PubMed ID: 7581588
[TBL] [Abstract][Full Text] [Related]
11. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
Le Coutour X
NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
[TBL] [Abstract][Full Text] [Related]
12. Use of HRT and the subsequent risk of cancer.
Beral V; Banks E; Reeves G; Appleby P
J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
[TBL] [Abstract][Full Text] [Related]
13. Second cancer following cancer of the female genital system in Connecticut, 1935-82.
Curtis RE; Hoover RN; Kleinerman RA; Harvey EB
Natl Cancer Inst Monogr; 1985 Dec; 68():113-37. PubMed ID: 4088293
[TBL] [Abstract][Full Text] [Related]
14. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
Kaunitz AM
J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
[TBL] [Abstract][Full Text] [Related]
15. Contraception and the big "C".
Chandran R
Malays J Reprod Health; 1992 Jun; 10(1):1-5. PubMed ID: 12345024
[TBL] [Abstract][Full Text] [Related]
16. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.
Bernstein L
Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):288-96. PubMed ID: 16611204
[TBL] [Abstract][Full Text] [Related]
17. [Do sex steroids cause breast and genital cancers? Epidemiologic data--the current status (July 1993)].
Beller FK
Geburtshilfe Frauenheilkd; 1993 Oct; 53(10):657-66. PubMed ID: 8270146
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptives and cancer of the reproductive organs.
Huezo C
IPPF Med Bull; 1985 Dec; 19(6):3-4. PubMed ID: 12267511
[TBL] [Abstract][Full Text] [Related]
19. Hormonal contraception and cancer.
Drife J; Guillebaud J
Br J Hosp Med; 1986 Jan; 35(1):25-9. PubMed ID: 3955285
[TBL] [Abstract][Full Text] [Related]
20. OCs and genital tract malignancies.
Herbst AL
Dialogues Contracept; 1994; 4(3):5-7. PubMed ID: 12345575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
